These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18672578)

  • 1. [Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate].
    Adam Z; Krikavová L; Krejcí M; Mechl M; Pour L; Moulis M; Vanícek J; Neumann C; Navrátil M; Veselý K; Vorlícek J
    Vnitr Lek; 2008 Jun; 54(6):653-64. PubMed ID: 18672578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful treatment of angiomatosis with thalidomide and interferon alpha. A description of five cases and overview of treatment of angiomatosis and proliferating hemangiomas].
    Adam Z; Pour L; Krejcí M; Pourová E; Synek O; Zahradová L; Navrátil M; Mechl M; Nebeský T; Neubauer J; Feit J; Vokurková J; Král Z; Bednarík O; Slampa P; Dolezalová H; Hájek R; Mayer J
    Vnitr Lek; 2010 Aug; 56(8):810-23. PubMed ID: 20845613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide].
    Adam Z; Pour L; Matýšková M; Krejčí M; Tomíška M; Szturz P; Rehák Z; Koukalová R; Křikavová L; Nebeský T; Neuman C; Navrátil M; Hájek R; Král Z; Mayer J
    Vnitr Lek; 2012 Feb; 58(2):145-53. PubMed ID: 22463096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Six-year follow-up of a patient with multiple angiomatosis involving skeleton, thoracic and abdominal cavities and the gut wall].
    Adam Z; Matýšková M; Tomíška M; Rehák Z; Koukalová R; Křikavová L; Pour L; Krejčí M; Szturz P; Zahradová L; Mechl M; Moulis M; Vaníček J; Neuman C; Navrátil M; Veselý K; Hájek R; Mayer J
    Klin Onkol; 2012; 25(1):47-62. PubMed ID: 22348220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
    Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
    Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The benefit of new angiogenesis (bevacizumab and aflibercept) inhibitors for multiple angiomatosis therapy: a case report].
    Brančíková D; Ostřížková L; Adam Z; Nebeský T; Pour L; Král Z; Mayer J
    Vnitr Lek; 2017; 63(10):672-678. PubMed ID: 29127751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon alpha-2a in the treatment of diffuse thoracic angiomatosis in adulthood--a ase report].
    Eichler A; Ukena D; Wilkens H; Reitnauer K; Girmann M; Remberger K; Kramann B; Sybrecht GW
    Pneumologie; 2000 Jun; 54(6):243-8. PubMed ID: 10934894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recurrent hemoptysis as initial symptom of a thoracic angiomatosis in an adult patient].
    Bastian D; Mödl B; Nentwich K; Engel G; Brunner E; Holper K
    Pneumologie; 2002 Nov; 56(11):689-94. PubMed ID: 12442210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols.
    Pacheco AV; Rasila K; Lee SJ; Rabinowitz I; Elias L; Lee FC; Verschraegen CF
    Urol Oncol; 2008; 26(6):610-5. PubMed ID: 18367103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic bone angiomatosis: a case report treated with aminobisphosphonates and review of the literature.
    Marcucci G; Masi L; Carossino AM; Franchi A; Capanna R; Sinigaglia L; Brandi ML
    Calcif Tissue Int; 2013 Nov; 93(5):462-71. PubMed ID: 23836156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.
    Clark PE; Hall MC; Miller A; Ridenhour KP; Stindt D; Lovato JF; Patton SE; Brinkley W; Das S; Torti FM
    Urology; 2004 Jun; 63(6):1061-5. PubMed ID: 15183950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Gorham-Stout disease with zoledronic acid and interferon-α: a case report and literature review.
    Kuriyama DK; McElligott SC; Glaser DW; Thompson KS
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):579-84. PubMed ID: 20962674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma.
    Ciepłuch H; Baran W; Hellmann A
    Med Sci Monit; 2002 Apr; 8(4):PI31-6. PubMed ID: 11951079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Schnitzler syndrome--report on a fourteen-year course of the disease and an overview of information on the disease].
    Adam Z; Krejcí M; Pour L; Neubauer J; Prásek J; Hájek R
    Vnitr Lek; 2008 Dec; 54(12):1140-53. PubMed ID: 19140523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis.
    Bauer JA; Morrison BH; Grane RW; Jacobs BS; Borden EC; Lindner DJ
    J Interferon Cytokine Res; 2003 Jan; 23(1):3-10. PubMed ID: 12639293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
    Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M
    Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alfa-2b three times daily and thalidomide in the treatment of metastatic renal cell carcinoma.
    Hernberg M; Virkkunen P; Bono P; Ahtinen H; Mäenpää H; joensuu H
    J Clin Oncol; 2003 Oct; 21(20):3770-6. PubMed ID: 14551295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma.
    Yildirim ND; Ayer M; Küçükkaya RD; Alpay N; Mete O; Yenerel MN; Yavuz AS; Nalçaci M
    Jpn J Clin Oncol; 2007 Sep; 37(9):704-7. PubMed ID: 17709605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemomediastinum and bilateral hemothorax with extensive angiomatosis of anterior mediastinum.
    Karimi S; Mohammadi F; Pejhan S; Bakhshayeshkaram M; Akhavan-Azaril P; Bahadori M
    Monaldi Arch Chest Dis; 2006 Sep; 65(3):172-4. PubMed ID: 17220109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of low-dose thalidomide and interferon alpha-2b in patients with metastatic melanoma who failed prior treatment.
    Solti M; Berd D; Mastrangelo MJ; Sato T
    Melanoma Res; 2007 Aug; 17(4):225-31. PubMed ID: 17625452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.